Among them, PLAC8 is a promising diagnostic biomarker that modulates the PI3K/Akt/mTOR signaling pathway in patients with IC/BPS, which provides new insights into the future diagnosis of IC/BPS. This evidence concerns the gene MTOR and Bartsocas-Papas syndrome 1.